Voncken FEM, et al. - Researchers pursued a comparison of long-term outcomes between younger (below 70 y) and older (70 y and above) esophageal cancer patients treated with curative intent between 1998 and 2013. Findings revealed that long-term outcomes of older esophageal cancer patients (70 y and above) selected for treatment with neoadjuvant chemoradiotherapy followed by surgery or definitive chemoradiotherapy were comparable with the outcomes of their younger counterparts. In esophageal cancer patients, advanced age alone should not be a contraindication for potentially curative chemoradiotherapy-based treatment.